All In Biotech

Free tool

FAERS Monitor: Genotropin Preservative Free

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020280 or its brand name (Genotropin Preservative Free, Somatropin). Reports on generic versions are filed under their own applications.

Reports

53,357

Serious

11,105

21% of reports

Hospitalization

4,263

Death reported

900

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug dose omission by device18,613
  • device leakage9,818
  • device breakage8,090
  • device mechanical issue7,703
  • device information output issue7,074
  • device issue5,025
  • wrong technique in device usage process4,667
  • device use error3,272
  • poor quality device used3,103
  • device physical property issue2,983
  • device use issue2,625
  • device delivery system issue2,349
  • device defective2,119
  • device malfunction2,014
  • incorrect dose administered by device1,744

Reports by year received

View as table
YearReports
2004220
2005196
2006224
2007246
2008187
2009317
2010563
2011493
20121,581
2013489
2014557
2015733
2016921
20171,186
20181,911
20191,657
20201,894
20213,374
20225,194
20238,591
20249,365
20258,370
20265,088

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,802 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device information output issueSignal7,0743867.03583.32,526,322
device mechanical issueSignal7,703503.5487.41,695,834
device physical property issueSignal2,983250.6239.5453,054
poor quality device usedSignal3,103176.0168.8373,131
drug dose omission by deviceSignal18,613122.6120.81,717,611
device leakageSignal9,818115.1112.7860,697
device breakageSignal8,09097.895.6622,160
device use issueSignal2,62569.466.6150,515
device defectiveSignal2,11954.852.498,208
wrong technique in device usage processSignal4,66743.642.4175,396
device use errorSignal3,27240.939.5115,443
device delivery system issueSignal2,34936.935.475,071
incorrect dose administered by deviceSignal1,74428.026.742,457
device issueSignal5,02523.322.7101,834
device malfunctionSignal2,01411.611.119,005

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.